CIK 0001544227 · Non-accelerated filer<br>Smaller reporting company
Tempest Therapeutics, Inc.
Sign in to watch- Ticker
- TPST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 451472564
- Phone
- 415-798-8589
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE, CA, 94005
- Former names
- Millendo Therapeutics, Inc., OvaScience, Inc.
- 8-K Event Exit or restructuring costs
- 8-K Event Agreement ended · Regulation FD disclosure
- 8-K Event Shareholder rights changed
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Delisting notice
- 8-K Event Material agreement · Shareholder rights changed · Shareholder vote results
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 7 of 53 · 1,055 filings